The global bronchodilators market size was valued at USD 28,512.4 million in 2021 and is poised to grow at a significant CAGR of 5.4% during the forecast period 2022-28. Bronchodilators are majorly classified based on their duration of action such as short-acting and long-acting. Majorly used bronchodilators are include sympathomimetics, phosphodiesterase inhibitors, and anticholinergics among others. Bronchodilators are medications that relax the muscles that constrict the airways. Bronchodilators widen the airway, allowing more air to flow in and out. Furthermore, rising use of bronchodilators for cystic fibrosis treatment propels the market forward. However, the market is expected to be hampered by bronchodilator side effects and regulatory regulations about the safety and efficacy of bronchodilators.

View Detailed Report Description at  https://precisionbusinessinsights.com/market-reports/global-bronchodilators-market/  

Increase in the aging population coupled with rise in prevalence of various lung diseases such as asthma and COPD surge the global bronchodilators market. Moreover, rise in R&D expenditure for the development newer drugs, increase in geriatric population, environmental factors such as air pollution, rise in incidence of respiratory disorders in children, government initiation to improve awareness about the lung diseases, technological advancements of the inhalation devices, and rise in disposable income are propel the global market over the forecast years.  

The global bronchodilators market segmentation:
1) By Drug Class: Phosphodiesterase Inhibitors, Anticholinergics, Sympathomimetics, Combination Drugs.
2) By Route of Administration: Oral, Parenteral, Inhalation.
3) By Disease Type: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Others.
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies.

Request sample report at  https://precisionbusinessinsights.com/request-sample?product_id=24258            

The bronchodilators market research report gives a comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America was the largest region in the bronchodilators market report, accounting for the highest share in 2021. It was followed by Asia Pacific, and then the other regions.

The bronchodilators market key players are Novartis AG (Switzerland), Merck & Co. Inc. (U.S.), AstraZeneca plc (U.K.), GlaxoSmithKline (U.S.), Aquinox Pharmaceuticals (Canada), MediciNova, Inc. (U.S.), Gilead Sciences, Inc. (U.S.), Biomarck Pharmaceuticals (U.S.).

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747